title: An insert-based enzymatic cell culture system to rapidly and reversibly induce hypoxia: investigations of hypoxia-induced cell damage, protein expression and phosphorylation in neuronal IMR-32 cells.
abstract: Ischemia-reperfusion injury and tissue hypoxia are of high clinical relevance because they are associated with various pathophysiological conditions such as myocardial infarction and stroke. Nevertheless, the underlying mechanisms causing cell damage are still not fully understood, which is at least partially due to the lack of cell culture systems for the induction of rapid and transient hypoxic conditions. The aim of the study was to establish a model that is suitable for the investigation of cellular and molecular effects associated with transient and long-term hypoxia and to gain insights into hypoxia-mediated mechanisms employing a neuronal culture system. A semipermeable membrane insert system in combination with the hypoxia-inducing enzymes glucose oxidase and catalase was employed to rapidly and reversibly generate hypoxic conditions in the culture medium. Hydrogen peroxide assays, glucose measurements and western blotting were performed to validate the system and to evaluate the effects of the generated hypoxia on neuronal IMR-32 cells. Using the insert-based two-enzyme model, hypoxic conditions were rapidly induced in the culture medium. Glucose concentrations gradually decreased, whereas levels of hydrogen peroxide were not altered. Moreover, a rapid and reversible (on-off) generation of hypoxia could be performed by the addition and subsequent removal of the enzyme-containing inserts. Employing neuronal IMR-32 cells, we showed that 3 hours of hypoxia led to morphological signs of cellular damage and significantly increased levels of lactate dehydrogenase (a biochemical marker of cell damage). Hypoxic conditions also increased the amounts of cellular procaspase-3 and catalase as well as phosphorylation of the pro-survival kinase Akt, but not Erk1/2 or STAT5. In summary, we present a novel framework for investigating hypoxia-mediated mechanisms at the cellular level. We claim that the model, the first of its kind, enables researchers to rapidly and reversibly induce hypoxic conditions in vitro without unwanted interference of the hypoxia-inducing agent on the cultured cells. The system could help to further unravel hypoxia-associated mechanisms that are clinically relevant in various tissues and organs.
authors.affiliation: Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein Schwanenweg 21, 24105 Kiel, Germany.
authors.forename: Ying
authors.initials: Y
authors.lastname: Huang
authors.forename: Karina
authors.initials: K
authors.lastname: Zitta
authors.forename: Berthold
authors.initials: B
authors.lastname: Bein
authors.forename: Markus
authors.initials: M
authors.lastname: Steinfath
authors.forename: Martin
authors.initials: M
authors.lastname: Albrecht
mesh_terms: D002374:Catalase / Q000378:metabolism*; D015687:Cell Hypoxia; D002460:Cell Line; D005949:Glucose Oxidase / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism; D010766:Phosphorylation
chemical_list: D005949:Glucose Oxidase; D002374:Catalase
references.citation: Am J Physiol Cell Physiol. 2002 Feb;282(2):C227-41
references.pmid: 11788333
references.citation: Eur J Neurosci. 2004 Aug;20(4):937-46
references.pmid: 15305862
references.citation: Biochem J. 1997 Aug 15;326 ( Pt 1):1-16
references.pmid: 9337844
references.citation: J Nucl Med. 2008 Jun;49 Suppl 2:129S-48S
references.pmid: 18523070
references.citation: Eur J Pharmacol. 2010 Oct 25;645(1-3):39-46
references.pmid: 20655305
references.citation: Exp Cell Res. 2012 Apr 15;318(7):828-34
references.pmid: 22342953
references.citation: Neurosci Lett. 2008 Jun 13;438(1):38-41
references.pmid: 18468794
references.citation: J Pathol. 2005 Jul;206(3):291-304
references.pmid: 15906272
references.citation: Circ Res. 2005 Nov 11;97(10):955-7
references.pmid: 16284185
references.citation: J Neurosci. 1993 Aug;13(8):3510-24
references.pmid: 8101871
references.citation: PLoS One. 2012;7(12):e51093
references.pmid: 23251428
references.citation: PLoS Med. 2006 Mar;3(3):e47
references.pmid: 16417408
references.citation: Adv Exp Med Biol. 2006;557:25-53
references.pmid: 16955703
references.citation: Science. 1997 Oct 24;278(5338):687-9
references.pmid: 9381178
references.citation: J Clin Invest. 2002 May;109(9):1133-7
references.pmid: 11994400
references.citation: Nat Med. 2011 Nov 07;17(11):1391-401
references.pmid: 22064429
references.citation: Endothelium. 2007 Jul-Oct;14(4-5):227-31
references.pmid: 17922339
references.citation: Adv Med Sci. 2009;54(2):121-35
references.pmid: 20022860
references.citation: Free Radic Res. 2007 Jul;41(7):788-97
references.pmid: 17577739
references.citation: Radiat Oncol. 2011 Apr 10;6:35
references.pmid: 21477371
references.citation: Mol Endocrinol. 2000 Jun;14(6):848-62
references.pmid: 10847587
references.citation: Cancer Lett. 2013 Feb 28;329(2):197-206
references.pmid: 23142284
references.citation: J Cell Sci. 2003 Jul 1;116(Pt 13):2677-85
references.pmid: 12746487
references.citation: J Exp Bot. 2012 Jun;63(11):4123-31
references.pmid: 22451722
references.citation: Paediatr Child Health. 2006 May;11(5):278-82
references.pmid: 19030289
references.citation: Trends Pharmacol Sci. 2004 May;25(5):259-64
references.pmid: 15120492
references.citation: Mol Med. 2012 Feb 10;18:29-37
references.pmid: 22009279
references.citation: N Engl J Med. 1985 Jan 17;312(3):159-63
references.pmid: 2981404
references.citation: Cell. 1997 Oct 17;91(2):231-41
references.pmid: 9346240
references.citation: Mol Cell Biol. 2001 Sep;21(17):5797-805
references.pmid: 11486019
references.citation: Cell. 2012 Feb 3;148(3):399-408
references.pmid: 22304911
references.citation: Genes Dev. 2003 Nov 1;17(21):2614-23
references.pmid: 14597660
references.citation: Radiat Res. 2008 Nov;170(5):651-60
references.pmid: 18959466
references.citation: Cell Death Differ. 2009 Mar;16(3):368-77
references.pmid: 18846109
references.citation: Eur J Pharmacol. 2010 Feb 25;628(1-3):11-8
references.pmid: 19917279
references.citation: Nature. 1992 Mar 26;356(6367):356-8
references.pmid: 1549180
references.citation: Anaesthesia. 2013 Jan;68(1):31-9
references.pmid: 23088185
references.citation: J Biol Chem. 1998 Dec 11;273(50):33533-9
references.pmid: 9837934
references.citation: Chin J Physiol. 2011 Dec 31;54(6):399-405
references.pmid: 22229507
references.citation: Am J Pathol. 2004 Jun;164(6):1875-82
references.pmid: 15161623
references.citation: Curr Cancer Drug Targets. 2008 Feb;8(1):19-26
references.pmid: 18288940
references.citation: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H821-8
references.pmid: 18055522
references.citation: J Neurophysiol. 2002 Aug;88(2):639-49
references.pmid: 12163517
references.citation: Br Med J. 1886 Mar 27;1(1317):587
references.pmid: 20751512
references.citation: Toxicol Appl Pharmacol. 2012 Nov 1;264(3):324-34
references.pmid: 22982409
references.citation: FEBS Lett. 1998 Nov 13;439(1-2):168-72
references.pmid: 9849900
references.citation: Oncogene. 1999 Nov 22;18(49):6910-24
references.pmid: 10602466
references.citation: J Appl Physiol (1985). 2007 Aug;103(2):464-73
references.pmid: 17446404
references.citation: Am J Respir Cell Mol Biol. 2003 Jan;28(1):80-5
references.pmid: 12495935
references.citation: Cancer Res. 1970 Aug;30(8):2110-8
references.pmid: 5459762
references.citation: J Biol Chem. 2011 Dec 30;286(52):44788-98
references.pmid: 22084246
references.citation: Am J Physiol Lung Cell Mol Physiol. 2001 Oct;281(4):L1021-7
references.pmid: 11557606
references.citation: Free Radic Biol Med. 2000 Dec 15;29(12):1291-301
references.pmid: 11118819